Goldman Sachs Group Inc Eucrates Biomedical Acquisition Corp. Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 May 14, 2024	SELL	$9.89 - $10.0 $247,250 - $250,000	-25,000 Reduced 44.95%	30,622 $307,000
Q3 2022 Nov 10, 2022	SELL	$9.89 - $10.0 $247,250 - $250,000	-25,000 Reduced 44.95%	30,622 $0
Q2 2022 May 14, 2024	BUY	$9.85 - $9.91 $547,876 - $551,214	55,622 New	55,622 $550,000
Q2 2022 Aug 15, 2022	SELL	$9.85 - $9.91 $4.91 Million - $4.94 Million	-498,000 Reduced 89.95%	55,622 $550,000
Q1 2022 May 16, 2022	BUY	$9.76 - $9.85 $5.06 Million - $5.11 Million	518,510 Added 1476.73%	553,622 $5.45 Million
Q4 2021 Feb 14, 2022	SELL	$9.75 - $9.85 $20,377 - $20,586	-2,090 Reduced 5.62%	35,112 $343,000
Q3 2021 Nov 10, 2021	BUY	$9.65 - $9.99 $358,999 - $371,647	37,202 New	37,202 $364,000

About Eucrates Biomedical Acquisition Corp.

Ticker EUCR
Exchange
Sector Financial Services
Industry Shell Companies
Shares Outstandng 13,459,100

More about EUCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.